Susceptibility testing of herpes simplex type 1 (HSV-1) and type 2 viruses to cytosine arabinoside (Ara-C) has been standardized under conditions of optimal reproducibility, susceptibility, and simplicity. Standard Clinically useful antibiotics are usually found among those antibiotics which possess marked in vitro activity against pathogenic bacteria. Determination of antibiotic susceptibilities of bacterial isolates has great significance for rational therapy. At present, several drugs are useful in treatment of viral diseases: thiosemicarbazones in smallpox and vaccinia; 5-iodo-desoxyuridine (IUdR), cytosine arabinoside (Ara-C), and adenine arabinoside, (Ara-A) in herpesvirus infections. Virus isolates are routinely not tested for in vitro susceptibility to drugs. This paper describes a simple, standardized method for susceptibility testing of herpesviruses to Ara-C based on inhibition of cytopathic effect (CPE). This method can be modified to measure virus inhibitory titers (VIT) of body fluids.
viruses to cytosine arabinoside (Ara-C) has been standardized under conditions of optimal reproducibility, susceptibility, and simplicity. Standard conditions were defined as virus inoculum of 101 5 to 102.5 TCID5o, WI-38 strain of lung fibroblasts, 2-day incubation, and observation of virus cytopathic effect after staining by the May-Greenwald-Giemsa method. The variability of minimum inhibitory concentration (MIC) of cytopathic effect was fourfold within each test and sixfold in successive assays. MIC values of all seven tested HSV-1 strains were in the range of 0.25 to 0.75 Mg per ml, whereas four of nine HSV-2 strains had MIC values of 0.9 ,g per ml and greater. A similar method can be used for assay of virus inhibitory titers of body fluids.
Clinically useful antibiotics are usually found among those antibiotics which possess marked in vitro activity against pathogenic bacteria. Determination of antibiotic susceptibilities of bacterial isolates has great significance for rational therapy. At present, several drugs are useful in treatment of viral diseases: thiosemicarbazones in smallpox and vaccinia; 5-iodo-desoxyuridine (IUdR), cytosine arabinoside (Ara-C), and adenine arabinoside, (Ara-A) in herpesvirus infections. Virus isolates are routinely not tested for in vitro susceptibility to drugs. This paper describes a simple, standardized method for susceptibility testing of herpesviruses to Ara-C based on inhibition of cytopathic effect (CPE). This method can be modified to measure virus inhibitory titers (VIT) of body fluids.
MATERIALS AND METHODS
Preparation of drug solution. Ara-C (Cytarabine, The Upjohn Co.) was prepared every 2 days at a concentration of 2 mg/ml in distilled water, sterilized by membrane filtration (Millipore Corp.), and diluted to appropriate concentrations in Eagle minimum essential medium (MEM) with Earle's salt solution, 2% dialyzed fetal calf serum, 100 units of penicillin per ml, and 100 ,ug of streptomycin per ml (MEMFCa2).
Viruses. Seven herpes simplex virus (HSV) type 1 (Fig. 1) ard conditions of assay, the reproducibility of MIC titers was within a sixfold range (Fig. 2) . MIC titers of two HSV-1 strains were consistently lower (2-to 16-fold) than MIC titers of two HSV-2 strains. DISCUSSION Ara-C has potent in vitro activity against HSV (1), VZV (11) , and CMV (R. W. Sidwell, G. Arnett, and F. M. Schabel, Jr., Chemotherapy, in press). Ara-C has the advantage over IUdR in vitro (1) and in vivo (13) in the lack of development of markedly resistant mutants in its presence. Mutants solidly resistant to IUdR develop rapidly (1) . Recent evidence (2) (3) (4) (5) (6) 9) suggests that treatment of disseminated herpes infections in man with Ara-C may be associated with successful outcome even when lower dosage is used (2) .
Several tests of in vitro susceptibility of HSV to drugs have been described. Buthala (1) measured Ara-C activity on the basis of reduction in plaque size and determined that plaque sizes were reduced even at the lowest concentration of Ara-C tested (0.1 ,g/ml). Person Recently, a test of susceptibility similar to ours of HSV and adenovirus to IUdR, 5-fluoro-2-deoxyuridine, and Ara-C has been described (14) . On the basis of the ratio of tissue tolerance to viral susceptibility, different antiviral spectra of the three drugs were found. Ara-C was the most effective drug against both types of HSV. In these experiments MIC values of HSV strains were determined in 10-fold dilutions which may have been the reason why greater resistance to Ara-C of some HSV-2 strains was not recognized.
In the present study, MIC values of four of nine HSV-2 strains were found higher than those of HSV-1 strains. In viral infections, direct extrapolation of therapeutic efficacy of antiviral agents from MIC and achievable blood levels is probably not warranted as (i) MIC titers are dependent on the conditions of the assay and (ii) tissue or lymphocyte levels may be more important for successful outcome than blood levels. Typing and sensitivity testing of herpesvirus isolates nevertheless may be of great importance for therapy if markedly resistant variants were encountered.
A modification of the procedure for MIC determination may be used for measuring VIT of body fluids before and during antiviral therapy. VIT is defined as the highest dilution of body fluid which inhibits a patient's virus. In this case, it is important to prevent inactivation of Ara-C by deaminase present in red blood cells and body fluids. Tetrahydrouridine, an inhibitor of Am-C deaminase, should be added to the specimen immediately after collection. The determination of VIT is performed similar to the MIC determination by using virus isolated from the patient as inoculum and body fluid at one-tenth or higher dilution in the overlay instead of Ara-C. Serum VIT of a patient with Hodgkin's disease and disseminated zoster was determined before and during antiviral therapy with Ara-C at the dose of 40 mg per m2 per day by continuous intravenous infusion. The serum VIT was 1:5 before therapy and rose to 1:200 during therapy concomitant with clinical improvement. Neutralizing antibody was absent in both of these samples. Interferon titers, unfortunately, were not determined.
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